Clinical Trial Update: The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer [Phase 2]

View source ↗

Summary

Update on the PRECISION trial, a Phase II study evaluating breast-conserving surgery without adjuvant radiotherapy for favorable-risk breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer Radiation | Phase 2 | Status: ACTIVE_NOT_RECRUITING